Nutex Health Announces Q2 2025 Financial Results Release and Conference Call
ByAinvest
Saturday, Aug 9, 2025 4:38 pm ET1min read
NUTX--
Investors and financial professionals can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the designated participant link [2]. For those unable to attend the live call, a recording will be available on the company’s website.
Nutex Health operates 24 micro hospitals across 11 states, with a market capitalization of $506.35 million as of July 2, 2025. The company's significant insider ownership stands at 35.81% [1].
Analysts expect Nutex Health to report a 145.4% increase in revenue to $186.686 million for the quarter ending June 30, 2025, compared to $76.08 million a year ago. The mean estimate for earnings per share (EPS) is a loss of $1.58, with a "buy" rating from analysts [4].
The upcoming financial results will provide insights into Nutex Health's performance during the second quarter of 2025, following the strong growth reported in the first quarter of the year. The company's ability to execute its growth strategy and navigate regulatory changes will be key factors to watch [1].
References:
[1] https://www.nutexhealth.com/nutex-health-schedules-2025-second-quarter-financial-results-release-and-conference-call/
[2] https://www.stocktitan.net/news/NUTX/nutex-health-schedules-2025-second-quarter-financial-results-release-gtqrwjpqugi6.html
[4] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW0N6:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/
Nutex Health will release Q2 2025 financial results on August 14, 2025, after market close, and hold a conference call on August 15, 2025, at 10:30 a.m. ET. Interested parties can dial in or access the call via a designated link. The company operates 24 micro hospitals across 11 states and has a market cap of $506.35 million, with significant insider ownership at 35.81%.
Nutex Health Inc. (NASDAQ: NUTX), a physician-led healthcare delivery system, has scheduled the release of its second quarter 2025 financial results for August 14, 2025, after the close of the market. The company will discuss these results during a conference call on August 15, 2025, at 10:30 a.m. ET [1].Investors and financial professionals can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the designated participant link [2]. For those unable to attend the live call, a recording will be available on the company’s website.
Nutex Health operates 24 micro hospitals across 11 states, with a market capitalization of $506.35 million as of July 2, 2025. The company's significant insider ownership stands at 35.81% [1].
Analysts expect Nutex Health to report a 145.4% increase in revenue to $186.686 million for the quarter ending June 30, 2025, compared to $76.08 million a year ago. The mean estimate for earnings per share (EPS) is a loss of $1.58, with a "buy" rating from analysts [4].
The upcoming financial results will provide insights into Nutex Health's performance during the second quarter of 2025, following the strong growth reported in the first quarter of the year. The company's ability to execute its growth strategy and navigate regulatory changes will be key factors to watch [1].
References:
[1] https://www.nutexhealth.com/nutex-health-schedules-2025-second-quarter-financial-results-release-and-conference-call/
[2] https://www.stocktitan.net/news/NUTX/nutex-health-schedules-2025-second-quarter-financial-results-release-gtqrwjpqugi6.html
[4] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW0N6:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet